January 2, 2013

Rite Aid announced a special series of 50th Anniversary customer appreciation savings as the culmination of RA50, its 50th anniversary celebration, which began last September.

January 2, 2013

Wall Street on Wednesday celebrated the "fiscal cliff" compromise as stocks across the board were trading up by some 200 basis points. As of noon, the Dow was up 1.7% and Nasdaq 2.3%.

January 2, 2013

Ulta Beauty is helping beauty mavens ring in the New Year with resolutions designed to create healthy skin all year long.

January 2, 2013

Walgreens on Wednesday announced that all Walgreens locations will host a "Night at the W" to celebrate the retail pharmacy operator's involvement in the People's Choice Awards.

January 2, 2013

To meet growing consumer demand for healthier choices, Whole Foods Market is introducing Engine 2 Plant-Strong products, a new line of plant-based, minimally processed snacks, breakfast items and pantry staples.

January 2, 2013

Zak Designs is looking to expand its environmental commitment by launching a new line of dinnerware, serveware and kitchen prep items, all made from recycled melamine.

December 28, 2012

Half of the primary care work-site health centers managed by Walgreens Employer Solutions Group have received AAAHC accreditation as patient-centered medical homes, with plans to have all of the company’s employer-based primary care centers accredited in the first half of 2013.

The news speaks to the quality of care delivered at Walgreens work sites, and as employers increasingly look for ways to curb healthcare costs and boost employee productivity, one can expect to see greater growth of such facilities going forward.

December 28, 2012

Boldface Group — a celebrity beauty licensing company that focuses on entertainment and designer opportunities in the market, including the "Khroma Beauty by Kourtney, Kim and Khloe Kardashian" brand — closed on $2 million in financing, the company has announced.

December 28, 2012

The incidence of influenza continued on an upward trajectory heading into the Christmas holiday, the Centers for Disease Control and Prevention reported.

December 28, 2012

Emergent BioSolutions announced that it has signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right to manufacture and sell VaxInnate’s pandemic influenza vaccine candidate in the United States.

December 28, 2012

Mylan on Friday announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its phenytoin chewable tablets USP in the 50 mg strength.

December 28, 2012

Teva Pharmaceuticals has received approval of their new drug application for topotecan hydrochloride injection, a treatment for small cell lung cancer, according to Food and Drug Administration records.

December 28, 2012

Hillshire Brands will introduce new products in the frozen breakfast category over the next few years in an effort for the company to become the most innovative meat-centric food company throughout North America.

December 28, 2012

A federal judge in Washington has dismissed a suit against the FDA brought up by Mylan for withholding approval for the company to sell a generic version of Novartis AG’s heart pill, Diovan.

December 28, 2012

Mylan on Friday announced that its partner Famy Care has received final approval from the Food and Drug Administration for its abbreviated new drug application for levonorgestrel and ethinyl estradiol Tablets USP in the 0.15mg/0.03mg strength.

December 28, 2012

The filing seeks to establish a fund to compensate individuals and families affected by a nationwide meningitis outbreak.

December 28, 2012

Solidifying Perrigo’s leadership position in topical foam-based generic prescription pharmaceuticals, the company announced it has signed a definitive merger agreement and completed the acquisition of Cobrek Pharmaceuticals.

December 28, 2012

Publix Super Markets on Thursday announced it has signed a lease for a second store in the Charlotte, N.C. area.

December 28, 2012

Rite Aid last week posted a third quarter profit of $61.9 million, marking the first time Rite Aid has been back in the quarterly black since June 2007. The quarterly report beat analyst expectations as the generic wave and retention of Express Scripts customers helped drive better-than-expected adjusted EBIDTA.

It's certainly a timely Christmas gift that Rite Aid delivered to those shareholders who believed in the Pennsylvania pharmacy operation when it's stock hovered around $1 per share; in the week following the third quarter conference call Rite Aid's stock price was up some 40%.

December 28, 2012

Teva Pharmaceuticals USA will delay the sales of generic versions of two Gilead Sciences HIV drugs until June 2013, the company stated.

December 28, 2012

Walgreens executives last week were upbeat looking ahead to calendar 2013, identifying the company's growing base of Well Experience format stores, the expanding role retail pharmacy plays in the delivery of health care and the promise to be realized through creating a global pharmacy operator as the three primary reasons lifting their spirits.

A new, fast-growing loyalty card program and closure to the company's nine-month separation from Express Scripts' pharmacy network are working wonders on improving the perception of Walgreens' future potential. A fortified faith in Walgreens' full potential never left the company's executive suite, of course. It's Wall Street analysts that still need a little convincing, and that may be coming along as well.

December 28, 2012

Watson Pharmaceuticals on Friday confirmed that Actavis, which was acquired by Watson in October, has filed an abbreviated new drug applications with the Food and Drug Administration seeking approval to market bortezomib, a generic version of Millennium Pharmaceuticals' Velcade.

December 27, 2012

Convenience retailer 7-Eleven has jumped on the "fresh" bandwagon, according to a report published last week in the New York Times.

December 27, 2012

In support of its December launch of the pseudoehedrine product Nexafed, Acura Pharmaceuticals recently kicked off a national e-mail campaign to help drive pharmacists to the Nexafed website with content specifically designed for the pharmacist audience, including infographics, graphic representations of study data and a behind-the-scenes look at Nexafed's abuse-deterrent technology.